Effect of the cannabinoid receptor–1 antagonist rimonabant on inflammation in mice with diet-induced obesity

We studied whether CB1 blockade with rimonabant has an anti-inflammatory effect in obese mice, and whether this effect depends on weight loss and/or diet consumption. High-fat diet (HFD)–induced obese mice were treated orally with rimonabant (HFD-R) or vehicle (HFD-V) for 4 weeks. Paired-feeding was...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wang, Qun, Perrard, Xiaoyuan Dai, Perrard, Jerry L., Mansoori, Amir, Smith, C. Wayne, Ballantyne, Christie M., Wu, Huaizhu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3272877/
https://ncbi.nlm.nih.gov/pubmed/20885384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oby.2010.213
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller